# Comparative Study to Evaluate Microbial Versus Porcine Pancreatic Enzyme Therapy in Chronic Pancreatitis

> **NCT07697352** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Asian Institute of Gastroenterology, India** · enrollment: 134 (estimated)

## Conditions studied

- Pancreatitis, Chronic
- Exocrine Pancreatic Insufficiency (EPI)

## Interventions

- **DIETARY_SUPPLEMENT:** Dietary Supplement: Pancreatic enzyme preparation from microbial source that contains amylase (6650 DU), lipase (13000 FIP), and protease (7120 HUT, 15 SAPU, 3000 PC).
- **OTHER:** Standard of care porcine pancreatic enzyme preparation: amylase (8000 U), lipase (25000 U), and protease (1000 U)

## Key facts

- **NCT ID:** NCT07697352
- **Lead sponsor:** Asian Institute of Gastroenterology, India
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2027-06
- **Final completion:** 2027-09
- **Target enrollment:** 134 (ESTIMATED)
- **Last updated:** 2026-08-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07697352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07697352, "Comparative Study to Evaluate Microbial Versus Porcine Pancreatic Enzyme Therapy in Chronic Pancreatitis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07697352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*